Strep throat treatment came with $25K medical bill

One New York City woman received the shock of a lifetime when her surprise medical bill to treat a cold and sore throat toped $25,000. The bill highlights the ongoing surge of healthcare prices and the issue of surprise billing, where patients receive high medical bills for services that were unknowingly conducted by out-of-network providers.

The sky-high bill was recently featured on the “Bill of the Month” series between Kaiser Health News and NPR. Alexas Kasdan, 40, of New York City, was treated quickly by her primary care physician for strep throat. During the visit, she was given a throat swab and blood test before she was prescribed antibiotics.

Later, her medical bill totaled $28,395.50, largely due to an out-of-network throat swab, of which her insurance covered $25,865.24. Fortunately, the doctor’s office said it would waive her required portion of the bill­­––more than $2,500.

The swab test covered a “sophisticated smorgasbord of DNA tests” for viruses and bacteria that are uncommon in outpatient setting practices. In addition, the test went to an out-of-network provider, a lab with list prices averaging 20 times higher than average. Another provider in network, LabCorp, would have only charged $653 for all the same tests.

See the full story below:

Amy Baxter

Amy joined TriMed Media as a Senior Writer for HealthExec after covering home care for three years. When not writing about all things healthcare, she fulfills her lifelong dream of becoming a pirate by sailing in regattas and enjoying rum. Fun fact: she sailed 333 miles across Lake Michigan in the Chicago Yacht Club "Race to Mackinac."

Around the web

Stryker, a global medtech company based out of Michigan, has kicked off 2025 with a bit of excitement. The company says Inari’s peripheral vascular portfolio is highly complementary to its own neurovascular portfolio.

RBMA President Peter Moffatt discusses declining reimbursement rates, recruiting challenges and the role of artificial intelligence in transforming the industry.

Mark Isenberg, executive vice president of Zotec Partners, discusses key developments that will reshape the specialty this year.